Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Cristina Bezzio"'
Autor:
Giorgia Ammirata, Maddalena Arigoni, Danilo Licastro, Gian Paolo Caviglia, Michela Disabato, Ghania Zubair, Cristina Bezzio, Simone Saibeni, Amedeo De Nicolò, Jessica Cusato, Alice Palermiti, Alessandra Manca, Emanuela Tolosano, Stefano Cozzini, Marcello Mancini, Fiorella Altruda, Antonio D’Avolio, Davide Giuseppe Ribaldone, Ugo Ala, Sharmila Fagoonee
Publikováno v:
Antioxidants, Vol 13, Iss 9, p 1047 (2024)
The relationship between serum 25-hydroxyvitamin D (25(OH)D) levels, genomic response to vitamin D (Vit.D), and positivity to SARS-CoV-2 remains understudied. In this pilot study, during the follow-up of patients with Inflammatory Bowel Disease (IBD)
Externí odkaz:
https://doaj.org/article/fb4157fcebf2423d91693aa35f59574f
Autor:
Giulia Migliorisi, Elisabetta Mastrorocco, Arianna Dal Buono, Roberto Gabbiadini, Gaia Pellegatta, Paola Spaggiari, Francesca Racca, Enrico Heffler, Edoardo Vincenzo Savarino, Cristina Bezzio, Alessandro Repici, Alessandro Armuzzi
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 14, p 4119 (2024)
Background/Objectives: Inflammatory bowel disease (IBD) and eosinophilic gastrointestinal diseases (EGIDs) are complex, multifactorial chronic inflammatory disorders affecting the gastrointestinal tract. Their epidemiology, particularly for eosinophi
Externí odkaz:
https://doaj.org/article/32a1d9ac041a4ac5a826ce977d967c6b
Autor:
Cristiana Bonifacio, Arianna Dal Buono, Riccardo Levi, Roberto Gabbiadini, Christian Reca, Cristina Bezzio, Marco Francone, Alessandro Armuzzi, Luca Balzarini
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 13, p 3953 (2024)
Background/Objectives: Inflammatory bowel diseases (IBDs) are chronic disorders that require close monitoring with imaging techniques such as magnetic resonance enterography (MRE). Standardization of radiological reports is crucial for the optimal ma
Externí odkaz:
https://doaj.org/article/c80d5b6674a047a8941423153f3ad1d8
Autor:
Cristina Bezzio, Marta Vernero, Stefania Costa, Alessandro Armuzzi, Gionata Fiorino, Sandro Ardizzone, Jenny Roselli, Sonia Carparelli, Ambrogio Orlando, Flavio Andrea Caprioli, Fabiana Castiglione, Chiara Viganò, Davide G. Ribaldone, Fabiana Zingone, Rita Monterubbianesi, Nicola Imperatore, Stefano Festa, Marco Daperno, Ludovica Scucchi, Antonio Ferronato, Luca Pastorelli, Eleonora Alimenti, Paola Balestrieri, Chiara Ricci, Maria Cappello, Carla Felice, Francesca Coppini, Patrizia Alvisi, Imma Di Luna, Viviana Gerardi, Angela Variola, Silvia Mazzuoli, Marco Vincenzo Lenti, Simone Saibeni, the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)’s COVID-19 Study Group
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background In Italy, the incidence of SARS-CoV-2 infection peaked in April and November 2020, defining two pandemic waves of coronavirus disease 2019 (COVID-19). This study compared the characteristics and outcomes of patients with inflammat
Externí odkaz:
https://doaj.org/article/a2bb224d7ded48e0a55299be5529046e
Autor:
Matteo Spertino, Roberto Gabbiadini, Arianna Dal Buono, Anita Busacca, Gianluca Franchellucci, Giulia Migliorisi, Alessandro Repici, Antonino Spinelli, Cristina Bezzio, Alessandro Armuzzi
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 8, p 2300 (2024)
Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by relapsing–remission phases. CD often requires surgical intervention during its course, mainly ileo-cecal/ileo-colonic resection. However, surge
Externí odkaz:
https://doaj.org/article/b0e7242850974484ab2b503656ae4280
Publikováno v:
Nutrients, Vol 16, Iss 8, p 1108 (2024)
Accumulating evidence from pre-clinical and clinical studies demonstrate the benefit of dietary fibers for inflammatory bowel disease (IBD). However, the majority of patients avoid or limit their consumption to manage their symptoms during the active
Externí odkaz:
https://doaj.org/article/191a649b2ba540fa8d9c367a9842d00f
Autor:
Marta Vernero, Cristina Bezzio, Davide G. Ribaldone, Flavio A. Caprioli, Massimo C. Fantini, Stefano Festa, Fabio S. Macaluso, Ambrogio Orlando, Daniela Pugliese, Sara Renna, Antonio Rispo, Edoardo V. Savarino, Angela Variola, Simone Saibeni
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 7, p 1857 (2024)
(1) Background: Inflammatory bowel disease (IBD) is frequently associated to other immune-mediated inflammatory diseases (IMIDs). This study aims at assessing physicians’ awareness of the issue and the current status of IMID management. (2) Methods
Externí odkaz:
https://doaj.org/article/ffa70a6e52274579bf49235262afde1c
Autor:
Marta Vernero, Simone Saibeni, Davide Scalvini, Carolina Cicalini, Lorenzo Chiarello, Silvia Nardi, Davide Giuseppe Ribaldone, Cristina Bezzio
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 4, p 1019 (2024)
(1) Background: Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders involving innate and adaptive immune responses. Despite primarily affecting the gut, recent insights highlight systemic implications, expanding our understanding be
Externí odkaz:
https://doaj.org/article/1a9e1c7af3044e229f1e8c755cd24e84
Autor:
Giulia Migliorisi, Giovanna Vella, Arianna Dal Buono, Roberto Gabbiadini, Anita Busacca, Laura Loy, Cristina Bezzio, Paolo Vinciguerra, Alessandro Armuzzi
Publikováno v:
Cells, Vol 13, Iss 2, p 142 (2024)
Background and aims: Inflammatory bowel diseases (IBD) are multifactorial chronic inflammatory disorders affecting the gastrointestinal tract. However, a broad spectrum of extraintestinal manifestations (EIMs) is associated with IBD, affecting severa
Externí odkaz:
https://doaj.org/article/d9c0f41371f14f1ba55d1d685555ba22
Autor:
Marta Vernero, Cristina Bezzio, Davide G. Ribaldone, Stefania Costa, Davide Scalvini, Elisa Tribocco, Gianpiero Manes, Simone Saibeni
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 21, p 6839 (2023)
(1) Background: GP2017 is one of the biosimilar drugs of adalimumab, one of the anti-TNF agents used for inflammatory bowel disease (IBD). To date, there is little real-world data about the use of GP2017 in IBD patients. The aim of our study was to e
Externí odkaz:
https://doaj.org/article/0ca4a53a589742bdb1541d8ba3d19b26